title: Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels.
abstract: The soluble urokinase plasminogen activator receptor (suPAR) has been detected in blood, plasma, serum, urine, ovarian cystic fluid, and cerebrospinal fluid. Elevated suPAR levels in plasma have been associated with negative outcomes in various diseases, such as bacteremia, sepsis, SIRS, cardiovascular disease, cancer, and tuberculosis. The primary aim of this study was to investigate whether suPAR can be detected in saliva from healthy individuals and thus, if saliva suPAR can be related to plasma suPAR, CRP, BMI, or gender. Blood and unstimulated whole saliva was collected from 20 healthy individuals (10 female and 10 male, median age of 28 years; range 21-41). CRP and suPAR were measured with ELISA in saliva and serum/plasma. suPAR was detected in all saliva samples in the 5.2-28.1 ng/mL range, with a median value of 17.1 ng/mL. Saliva suPAR was significantly higher (P < 0.001) but not correlated to plasma suPAR in healthy young adults with normal plasma suPAR levels. suPAR and CRP levels were correlated in blood but not in saliva. No correlation was found between BMI, age, or gender and suPAR in saliva.
authors.affiliation: Department of Biomedical Laboratory Science, Malmö University, Malmö, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Gustafsson
authors.forename: Vjosa
authors.initials: V
authors.lastname: Ajeti
authors.forename: Lennart
authors.initials: L
authors.lastname: Ljunggren
references.citation: Eur J Oral Sci. 2006 Feb;114(1):22-6
references.pmid: 16460337
references.citation: J Intern Med. 2010 Sep;268(3):296-308
references.pmid: 20561148
references.citation: Scand J Infect Dis. 2004;36(1):14-9
references.pmid: 15000553
references.citation: Eur J Clin Microbiol Infect Dis. 2008 May;27(5):375-83
references.pmid: 18197443
references.citation: Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1417-24
references.pmid: 21479972
references.citation: Arch Oral Biol. 1999 Dec;44(12):1027-34
references.pmid: 10669081
references.citation: J Immunol Methods. 2011 Oct 28;373(1-2):19-25
references.pmid: 21821037
references.citation: Inflammation. 2010 Dec;33(6):374-80
references.pmid: 20229356
references.citation: Dis Markers. 2009;27(3):157-72
references.pmid: 19893210
references.citation: Cancer Res. 1998 Aug 1;58(15):3294-8
references.pmid: 9699658
references.citation: Nat Rev Mol Cell Biol. 2002 Dec;3(12):932-43
references.pmid: 12461559
references.citation: Crit Care. 2011;15(1):R63
references.pmid: 21324198
references.citation: Postgrad Med. 2011 Jan;123(1):114-9
references.pmid: 21293091
references.citation: Biomark Insights. 2010 Jul 20;5:57-61
references.pmid: 20703322
references.citation: Brain Behav Immun. 2011 May;25(4):640-6
references.pmid: 21236331
references.citation: Atherosclerosis. 2011 May;216(1):237-43
references.pmid: 21354571
references.citation: J Biol Chem. 1991 May 15;266(14):8655-8
references.pmid: 1851152
references.citation: Int J Tuberc Lung Dis. 2002 Aug;6(8):686-92
references.pmid: 12150480
references.citation: Clin Biochem. 2011 Oct;44(14-15):1227-30
references.pmid: 21816136
references.citation: Ann Rheum Dis. 1999 Aug;58(8):488-92
references.pmid: 10419867
references.citation: Blood. 1998 Apr 1;91(7):2305-12
references.pmid: 9516128
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):609-18
references.pmid: 21239684
references.citation: J Clin Periodontol. 2000 Mar;27(3):149-56
references.pmid: 10743860